Treatment of Philadelphia-positive acute lymphocytic leukemia with tyrosine kinase inhibitors: What is the optimal regimen?

Source:http://linkedlifedata.com/resource/pubmed/id/20131307

Download in:

View as

General Info

PMID
20131307